日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation

Ad GV.EGR.TNF.11D(TNFerade™ Biologic)联合放化疗治疗复发性头颈癌并接受再放疗的患者的第一阶段剂量递增研究

T Y Seiwert, T Darga, D Haraf, E A Blair, K Stenson, E E W Cohen, J K Salama, V Villaflor, M E Witt, M W Lingen, R R Weichselbaum, E E Vokes

Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy

利用 TNF-alpha 增强肿瘤对放射治疗敏感性的转化策略

H J Mauceri, M A Beckett, H Liang, H G Sutton, S Pitroda, E Galka, E Efimova, T Darga, N N Khodarev, C R King, M C Posner, S Hellman, D W Kufe, R R Weichselbaum